NATR NATURES SUNSHINE PRODUCTS INC
Health Care · Russell 2000
Next earnings: not announced yet
What 3 analyst firms say about NATURES SUNSHINE PRODUCTS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
3 rated views · 4 analyst/firm records · 3 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on NATR from 3 analyst firms in the last 90 days (3 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Canaccord Genuity lowered its target from $36.00 (set 30 Jul 2026) to $25.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Susan K Anderson | Buy | 30 Oct 2026 | 25.00 USD |
| DA Davidson | Brian Holland | Buy | 10 Aug 2026 | 25.00 USD |
| DA Davidson | Matthew J Curtis | Buy | 6 Jul 2026 | 25.00 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:34 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.